Cargando…
USE OF RWD TO GENERATE RWE IN THE ALZHEIMER'S DISEASE SETTING: CHALLENGES AND FUTURE DIRECTIONS
There is considerable interest by many stakeholder groups in developing new therapies in Alzheimer’s disease (AD). Increasing interest in the treatment of pre-clinical disease and measurement of associated long term outcomes using RWD is being explored as the use of RCTs in this context can be limit...
Autor principal: | DiBello, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770276/ http://dx.doi.org/10.1093/geroni/igac059.773 |
Ejemplares similares
-
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
por: Ro, Sunhee K., et al.
Publicado: (2023) -
CHALLENGES RELATED TO DATA SOURCES FOR RWE IN AGING RESEARCH
por: Lu, Kevin
Publicado: (2022) -
Real world evidence (RWE) - Are we (RWE) ready?
por: Suvarna, Viraj Ramesh
Publicado: (2018) -
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
por: Maison, Patrick, et al.
Publicado: (2022) -
Using RWE research to extend clinical trials in diabetes: An example with implications for the future
por: Seeger, John D., et al.
Publicado: (2020)